UK's Dechra Spends $422.1M on Two Dutch Animal Pharmas Post author:Sam Post published:January 24, 2018 Post category:BioPharma The company struck the cash-and-share deals to boost its presence in Europe. Source: BioSpace You Might Also Like Top 10 R&D Scientist Skills in Demand April 26, 2017 Regulus Announces Pricing Of Public Offering Of Common Stock July 19, 2017 MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017
MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017
